Survivors And Workers Of The 9/11 WTC Tragedy Are Suffering From Different Forms Of Cancer, Receive Compensation under Zadroga Bill.
People are still feeling the effects of 9/11. Thousands of individuals volunteered to help in one way or another. Many others survived the ordeal of that day. After the World Trade Center (WTC) bombings, scores of survivors and volunteers that were in the area are now suffering from some form of cancer.
The 9/11 victims fund will cover all financial considerations, including lost income and expenses.
Over 9,000 lawsuits are in progress concerning the makers and distributers of Xarelto, a blood thinner that is produced by both Bayer AG and Janssen Pharmaceuticals, the latter being a subsidiary of the drug company Johnson & Johnson. Over 7,000 of these Xarelto lawsuits have been filed in Louisiana alone. Another 1,000 cases have been filed in Delaware, and an additional 1,000 filed in a state court in Pennsylvania. The plaintiffs of Xarelto claim the drug caused bleeding to the brain or intestine, which then lead to more severe side effects. These include hospitalization and death. The plaintiffs are accusing the defendants of not warning their patients of the severe dangers of the drug.
A California judge on Friday tossed a jury award of $417 million from Johnson & Johnson to a woman who claimed the company's baby powder gave her ovarian cancer, finding the parties and jurors had made errors and damages were excessive.
On the latest episode of Law360's Pro Say podcast, we discuss the NFL's recent legal challenges, the Supreme Court agreeing to hear cases about data privacy and competition among credit cards, the conviction of an auto racer and his attorney for a huge payday loan scheme, and a catfishing con artist that duped several firms.
An Illinois federal judge on Friday denied a bid by Abbott Laboratories to toss a suit alleging it failed to properly warn doctors about the risk of birth defects like spina bifida from the use of Depakote, rejecting the drugmaker's assertion that merely listing the probability of the defect on the drug's label was sufficient under […]
German drugmaker Boehringer Ingelheim Pharmaceuticals Inc. filed a pair of patent infringement suits Friday in New Jersey federal court over bids by Sandoz Inc. and Sun Pharmaceutical Industries to market generic versions of its cancer therapy drug.
Four Qualcomm Inc. executives escaped allegations they rushed a defective mobile chip to market after a California federal judge on Friday trimmed investors’ class action lawsuit, ruling they failed to prove the tech giant’s top brass lied about the chip in a way that cost shareholders money.
A three-judge panel for the D.C. Circuit on Friday nixed a lower court order requiring the federal government to allow an immigrant teenager to have an abortion, giving U.S. Health and Human Services until the end of the month for the young woman to be released to a sponsor.
Spanish construction firm Cobra Infraestructuras Hidraulicas SA has urged a Florida federal judge to deny a stay of its petition to vacate a $23 million arbitration award to a former subcontractor on a Guatemala hydroelectric project, saying a pending request for clarification cannot correct the tribunal's error.
General Motors Co.'s $120 million settlement with attorneys general of 49 states and the District of Columbia ending allegations that the automaker hid a potentially fatal defect in its cars represents a trend that's likely to grow of state attorneys general banding together to pursue product liability claims against manufacturers.
If Johnson & Johnson’s talcum powder products contained asbestos, a person using them on their child or on themselves could develop mesothelioma, a former Tulane pathology professor and asbestos expert testified in a California trial Friday for a woman alleging she developed the cancer in this way.